Joel A. Pearlman
Expertise in
18
conditions

Dr. Joel A. Pearlman

Ophthalmology
3 Parkcenter Dr, Ste 100, 
Sacramento, CA 
Accepting New Patients
Expertise in
18
conditions
3 Parkcenter Dr, Ste 100, 
Sacramento, CA 

Overview

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease.

Dr. Pearlman is highly rated in 18 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Retinal Detachment.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Baylor College Of Medicine

Specialties

Ophthalmology

Licenses

Ophthalmology in CA

Board Certifications

Ophthalmology

Fellowships

The Wilmer Eye Institute

Hospital Affiliations

Mercy San Juan Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 14 Less Insurance Carriers -

Locations

Vitreo Retinal Medical Group Inc
3 Parkcenter Dr, Ste 100, Sacramento, CA 95825

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase I, Open-Label, Multi-Center Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2798745 After 28 Day Repeat Oral Administration to Adults With Diabetic Macular Edema
Phase I, Open-Label, Multi-Center Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2798745 After 28 Day Repeat Oral Administration to Adults With Diabetic Macular Edema
Enrollment Status: Terminated
Publish Date: November 08, 2024
Intervention Type: Drug
Study Drug: GSK2798745
Study Phase: Phase 1
A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of RBM-007 Monotherapy and RBM-007 in Combination With Eylea® Compared to Eylea® Monotherapy
A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of RBM-007 Monotherapy and RBM-007 in Combination With Eylea® Compared to Eylea® Monotherapy
Enrollment Status: Completed
Publish Date: June 08, 2023
Intervention Type: Drug
Study Drugs: RBM-007 Injectable Solution, Aflibercept, Sham
Study Phase: Phase 2
A Multi-Center, Open Label, TOFU Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration
A Multi-Center, Open Label, TOFU Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration
Enrollment Status: Completed
Publish Date: June 08, 2023
Intervention Type: Drug
Study Drug: RBM-007
Study Phase: Phase 2
Phase 1/2 Open Label, Dose-escalation Study of the Safety and OcUlar Tolerability of a Single Intravitreal Injection of RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration (SUSHI)
Phase 1/2 Open Label, Dose-escalation Study of the Safety and OcUlar Tolerability of a Single Intravitreal Injection of RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration (SUSHI)
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

19 Total Publications

Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema.
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema.
Journal: Translational vision science & technology
Published: December 19, 2024
Similar Doctors
Expertise in
25
conditions
Dr. Glenn Yiu
Ophthalmology
Expertise in
25
conditions
Dr. Glenn Yiu
Ophthalmology

UC Davis Department Of Ophthalmology

4860 Y St Ste 2400, 
Sacramento, CA 
 (41.9 miles away)
916-734-6602
Languages Spoken:
English
See accepted insurances

Glenn Yiu is an Ophthalmologist in Sacramento, California. Dr. Yiu is highly rated in 25 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Cataract Removal.

Expertise in
29
conditions
Dr. Susanna Park
Ophthalmology
Expertise in
29
conditions
Dr. Susanna Park
Ophthalmology

UC Davis Department Of Ophthalmology

4860 Y St Ste 2400, 
Sacramento, CA 
 (41.9 miles away)
916-734-6602
Languages Spoken:
English
See accepted insurances

Susanna Park is an Ophthalmologist in Sacramento, California. Dr. Park is highly rated in 29 conditions, according to our data. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Vitrectomy, and Bone Marrow Aspiration.

Expertise in
27
conditions
Dr. Ala Moshiri
Ophthalmology
Expertise in
27
conditions
Dr. Ala Moshiri
Ophthalmology

UC Davis Department Of Ophthalmology

4860 Y St Ste 2400, 
Sacramento, CA 
 (41.9 miles away)
916-734-6074
Languages Spoken:
English
See accepted insurances

Ala Moshiri is an Ophthalmologist in Sacramento, California. Dr. Moshiri is highly rated in 27 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Color Blindness, and Vitrectomy.

Frequently Asked Questions about Dr. Joel A. Pearlman

How do I make an appointment with Dr. Joel A. Pearlman?

You can book an appointment with Dr. Joel A. Pearlman by calling their office at 916-454-4861. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joel A. Pearlman a top-rated expert for Age-Related Macular Degeneration (ARMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joel A. Pearlman is classified as an Distinguished expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joel A. Pearlman specialize in?

While Dr. Joel A. Pearlman is a Ophthalmology, they have specific expertise in Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Joel A. Pearlman participate in research or clinical trials?

Yes. Dr. Joel A. Pearlman has published 19 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Dr. Joel A. Pearlman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joel A. Pearlman accept my insurance?

Dr. Joel A. Pearlman accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 916-454-4861 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pearlman's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 11 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile